Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
January 18 2023 - 03:30PM
Business Wire
Johnson & Johnson (NYSE: JNJ) will participate in the SVB
Securities Global Biopharma Conference on Wednesday, February 15th.
Biljana Naumovic, Worldwide Vice President, Oncology and Peter
Lebowitz, Global Therapeutic Head, Oncology will represent the
Company in a virtual session scheduled at 1:00 p.m. (Eastern
Time).
This live audio webcast will be available to investors and other
interested parties by accessing the Johnson & Johnson website
at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs
after the webcast.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230118005064/en/
Investor Contact: RA-JJCUS-InvestorRel@ITS.JNJ.com
Media Contact: Jake Sargent (732) 524-1090
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Feb 2024 to Mar 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2023 to Mar 2024